Sign in

A/Prof Qingwei Luo

@qingweiluo.bsky.social
21 followers 16 following 2 posts

Associate Professor, The Daffodil Centre, The University of Sydney, and Cancer Council NSW

PostsRepliesMedia
A/Prof Qingwei Luo @qingweiluo.bsky.social · 17/08/2026
Cancer prevalence in Australia is projected to rise by 57% from 1.67m people in 2025 to 2.62m by 2050. Alongside expanding cancer services, stronger prevention efforts are essential to reduce future cancer burden. doi.org/10.1016/j.la... @lancetrh-wpac.bsky.social @daffodilcentre.org
022
A/Prof Qingwei Luo @qingweiluo.bsky.social · 26/09/2025
We’re thrilled to have our linked comment published in @thelancet.com The future of cancer control depends on decisive, collective action today. 🔗 Read it here: doi.org/10.1016/S014... 📄 Original article: doi.org/10.1016/S014... @daffodilcentre.org @sydney.edu.au
doi.org
Redirecting
031
Reposted by A/Prof Qingwei Luo
The Daffodil Centre @daffodilcentre.org · 08/04/2025
NEW RESEARCH🔬| We are excited to share the first long-term projections for cancer prevalence linked to key pan-tumour biomarkers in Australia. 🔍This study aims to inform health policy and healthcare planning for targeted therapies. 🌐Read the full article🔗 doi.org/10.1016/j.la...
041
Reposted by A/Prof Qingwei Luo
The Lancet Regional Health - Western Pacific @lancetrh-wpac.bsky.social · 07/04/2025
🆕 First long-term #projections for #cancer prevalence associated with key #PanTumour #biomarkers in #Australia to 2042, to inform health policy & planning for targeted therapies. #MedSky #OncSky @daffodilcentre.bsky.social @juliasteinberg.bsky.social @qingweiluo.bsky.social 🔗Check out full text!
thelancet.com
Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042
We present the first long-term projections for cancer prevalence associated with key pan-tumour biomarkers in Australia, to inform health policy and healthcare planning for targeted therapies.
034
Reposted by A/Prof Qingwei Luo
The Daffodil Centre @daffodilcentre.org · 01/04/2025
NEW RESEARCH🔬| This pilot, randomised waitlist-controlled trial aimed to evaluate the feasibility, acceptability, and safety of #iConquerFear, a self-guided online fear of cancer recurrence intervention for #OvarianCancer survivors. 🌐Read the full article🔗 doi.org/10.1186/s128...
143